I would like to receive WebMD’s Newsletter and other email updates from WebMD. What is GLP-1 and how does it work? How GLP-1 medications help with weight loss Who can benefit from GLP-1 ...

Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...

Kevin Lin, from Harvard Medical School in Boston, and colleagues assessed national trends and characteristics of patients with obesity who were prescribed GLP-1 RAs vs those undergoing metabolic ...

novel drugs and personalized health tools. One of the most impactful developments in recent years has been the rise of GLP-1s like semaglutide and tirzepatide — with roughly 12% of Americans ...

GLP-1 receptor agonists, like Wegovy and Ozempic, have taken center stage in obesity and diabetes treatment ... Food itself is one of the best therapeutic tools for long-term health — and ...

GLP-1 drugs can be prescribed for type 2 diabetes or obesity, and studies have shown they may be effective against other conditions—from polycystic ovarian syndrome (PCOS) to liver disease ...

Since semaglutide was approved by the FDA for weight loss under the brand name Wegovy in 2021, GLP-1 medications—originally ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Among those states that don’t cover the ...

Study Finds Bariatric Surgery Declined With Rise in GLP-1 Drugs to Treat Obesity Oct. 25, 2024 — A new study has examined a large sample of privately insured patients with obesity and found that ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Advertisement Under the Medicaid system ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers discovered. Among those states that don’t cover the drugs, ...